Laxation scFOS: The effect of ingesting 3 grams of scFOS in the form of chewable tablets (5 x 600mg) on volunteers presenting with mild to moderate constipation (> 3 and ≤ 5 bowel movements weekly) has been demonstrated in a placebo-controlled study. The experimental design consisted of an initial 2-week treatment regimen, followed by a 2-week non-treatment period and finally a 2-week placebo treatment period. Results are presented graphically below.
The results showed a significant increase in bowel movements for the scFOS treatment versus both placebo and non-intake periods. A corresponding significant increase was also observed in fecal biomass in favor of the scFOS treatment
Anti-Diarrheal scFOS: This study involved administering 2 to 5 grams scFOS daily to 93 children ages 1 to 14 suffering from acute diarrhea in an Indonesian Hospital Clinic. Twenty-five in the same age grouping received a matching placebo. The results (image below) showed a significant reduction in duration of hospital stay versus placebo.